Allows to leverage the noninvasive blood constituent monitoring capabilities of Masimo Rainbow SET pulse co-oximetry
Masimo has reported that St.Vincent Indianapolis Hospital has renewed its campus-wide contract for Masimo SET pulse oximetry technology. A Masimo customer since 2000, St.Vincent cites advanced monitoring technology, an upgradeable platform and new capabilities as key reasons for the six-year system-wide renewal of their technology standardization contract.
Masimo claims that continuing the standardization on Masimo SET pulse oximetry technology allows St.Vincent Hospital to leverage the noninvasive blood constituent monitoring capabilities of Masimo Rainbow SET pulse co-oximetry.
Masimo Rainbow SET is the technology platform capable of continuously and noninvasively measuring multiple blood constituents and parameters that previously required invasive procedures, including total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet), PVI for fluid responsiveness, and acoustic respiration rate (RRa), in addition to oxyhemoglobin (SpO2), pulse rate (PR), and perfusion index (PI).
The ability to immediately detect and treat potentially life-threatening conditions without having to draw blood and wait for the results, facilitates earlier and better clinical decisions for St.Vincent clinicians, said the company.